These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 24200315

  • 1. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
    Osaki M, Miyashita F, Koga M, Fukuda M, Shigehatake Y, Nagatsuka K, Minematsu K, Toyoda K.
    Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M, Arihiro S, Miyashita F, Yamamoto H, Yamada N, Nagatsuka K, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2013 Mar; 36(4):299-305. PubMed ID: 24135558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezène Y, Philippeau F, Honnorat J, Froment JC, Trouillas P.
    J Neurol Sci; 2004 Oct 15; 225(1-2):3-9. PubMed ID: 15465079
    [Abstract] [Full Text] [Related]

  • 6. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2012 Oct 15; 34(2):140-6. PubMed ID: 22854333
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of National Institutes of Health Stroke Scale Score in Predicting the Site of Arterial Occlusion in Acute Stroke: A Transcranial Doppler Study.
    Gupta D, Sharma A, Uchino K, Alexandrov AV, Khan K, Shuaib A, Saqqur M.
    J Stroke Cerebrovasc Dis; 2016 Sep 15; 25(9):2109-15. PubMed ID: 27468661
    [Abstract] [Full Text] [Related]

  • 8. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion<or=3 h and 3-6 h.
    Li YH, Li MH, Zhao ZG, Bai QK.
    Neurol India; 2009 Sep 15; 57(4):426-33. PubMed ID: 19770543
    [Abstract] [Full Text] [Related]

  • 9. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.
    Takagi T, Kato T, Sakai H, Nishimura Y.
    J Stroke Cerebrovasc Dis; 2014 Jan 15; 23(1):69-74. PubMed ID: 23164483
    [Abstract] [Full Text] [Related]

  • 10. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator.
    Wei XE, Zhao YW, Lu J, Li MH, Li WB, Zhou YJ, Li YH.
    Acta Radiol; 2015 Sep 15; 56(9):1119-26. PubMed ID: 25182802
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH, Lee DS, Nah HW, Cha JK.
    BMC Neurol; 2018 Mar 15; 18(1):30. PubMed ID: 29544461
    [Abstract] [Full Text] [Related]

  • 13. Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke.
    Muchada M, Rubiera M, Rodriguez-Luna D, Pagola J, Flores A, Kallas J, Sanjuan E, Meler P, Alvarez-Sabin J, Ribo M, Molina CA.
    Stroke; 2014 Apr 15; 45(4):1059-63. PubMed ID: 24603070
    [Abstract] [Full Text] [Related]

  • 14. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M, Tütüncü S, Fiebach JB, Scheitz JF, Audebert HJ, Nolte CH.
    J Stroke Cerebrovasc Dis; 2013 May 15; 22(4):550-3. PubMed ID: 23433783
    [Abstract] [Full Text] [Related]

  • 15. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
    Sakamoto Y, Koga M, Kimura K, Nagatsuka K, Okuda S, Kario K, Hasegawa Y, Okada Y, Yamagami H, Furui E, Nakagawara J, Shiokawa Y, Okata T, Kobayashi J, Tanaka E, Minematsu K, Toyoda K.
    Eur J Neurol; 2014 Mar 15; 21(3):419-26. PubMed ID: 24261412
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS, Lee KY, Han SW, Kim SH, Lee JY, Ahn SH, Kim DJ, Kim DI, Nam CM, Heo JH.
    J Neurol Sci; 2009 Jun 15; 281(1-2):69-73. PubMed ID: 19304298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
    Idei M, Sasaki T, Tanabe T, Muraoka K, Terada K, Meguro T, Hirotsune N, Nishino S.
    No Shinkei Geka; 2012 Jul 15; 40(7):585-91. PubMed ID: 22728535
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.